Microsoft (NASDAQ:MSFT)-backed OpenAI co-founder Sam Altman is gearing up to back Merge Labs, a new brain-computer interface startup that could go head-to-head with Elon Musk's Neuralink, the ...

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting ...

Over the last year, the feud between Silicon Valley heavyweights Sam Altman and Elon Musk has devolved into personal attacks, ...

The Financial Times reports today that OpenAI co-founder Sam Altman plans to invest in new brain-computer interface (BCI) venture Merge Labs.

Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is ...

Merge Labs, which aims to develop brain-computer interfaces, is in early talks to raise $250 million at an $850 million valuation from investors including OpenAI, the Financial Times reported. Merge ...

OpenAI co-founder Sam Altman is preparing to back a new brain-computer interface startup called Merge Labs that could be a ...

Sam Altman is preparing to co-found a new company funded by OpenAI that will go up against Elon Musk's Neuralink.

The brain chip company that has drawn interest from Sam Altman and his artificial intelligence business OpenAI is exploring ...

In a strategic move, OpenAI CEO Sam Altman is reportedly planning to invest in a brain implant startup, called Merge Labs, ...

Sam Altman is launching Merge Labs, an $850 million brain-computer interface startup, potentially funded by OpenAI's ventures ...

Merge Labs is a new Neuralink rival developing brain-computer interfaces. If you’ve enjoyed Elon Musk’s ongoing beef with ...